2011 annual financial data
Capricor Therapeutics 2011 Operating cash flow margin
Direct answer
Operating cash flow margin was -343.12%.
Operating income was -4,899,000 USD and net income was -4,885,000 USD.
Operating cash flow was -4,649,292 USD.
Get free Capricor Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,355,000 USD
- Operating income
- -4,899,000 USD
- Net income
- -4,885,000 USD
- Operating cash flow
- -4,649,292 USD